Becton, Dickinson, and Company (BDX) – Growth through BD2025 strategy

Becton Dickinson, and Company (BDX) (Q3FY23)

Stock Performance – Becton Dickinson’s stock price showed a volatile trend in past 3-months period. It gave 3.37% returns during the period. In the past 3 years, the stock has given returns of 21.46%. The stock has a 52-week high of $287.32 and its 52-week low is $215.90.

In the past 3 years, the stock has given returns of 21.46%. BDX has a 50-day moving Avg. and 200-day moving Avg. of $272.96 and $255.95, respectively.

Revenue Performance – BDX revenue was $4.9bn increased 5.1% as reported and 6.3% on a currency-neutral basis in Q3FY23. The revenue increased by 1.2% to $14.29bn in nine months of FY23 compared to $14.11bn in nine months of FY22

Company Guidance for FY23 – BDX expects revenues to be approximately $19.3bn for FY23. Revenue guidance now assumes base business currency-neutral revenue growth of 6.8% to 7.1% before the impact of the Surgical Instrumentation platform divestiture. This reflects an increase of 25 basis points at the mid – point to 7%, driven by strong third-quarter performance.

The company’s fiscal year 2023 adjusted diluted EPS guidance of $12.10 to $12.32.

Highlights

The company’s innovation-focused growth strategy is progressing well, with a robust pipeline set to deliver over 100 product launches by the end of fiscal year 2025. The innovation strategy is further bolstered by a significant surge of innovation in the field of Biosciences, contributing to growth and success.

This report is useful for M&A, business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– CrispIdea Segment Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10-Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– M&A Deals

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

Crispidea Coverage

No of Pages: 36

To download the previous quarter’s equity/report CLICK HERE

To Download other equity/ stock reports CLICK HERE

Follow our LinkedIn page for more updates.